Possible role of oxidative stress and immunological activation in mouse model of chronic fatigue syndrome and its attenuation by olive extract

https://doi.org/10.1016/j.jneuroim.2010.05.021Get rights and content

Abstract

Various putative theories involved in the development of chronic fatigue syndrome revolve around the role of stress, infection and oxidative stress. Scientific evidence highlighting the protective role of nutritional supplements in chronic fatigue syndrome is lacking. Based on these assumptions, the present study was designed to evaluate the effect of olive extract in a mouse model of immunologically-induced fatigue, wherein purified lipopolysaccharide (LPS) and Brucella abortus (BA) antigen were used as immunogens. The assessment of chronic fatigue syndrome was based on immobility period during chronic water-immersion stress test for 10 min daily. The stress-induced hyperalgesia was measured by tail withdrawal latency. Mice challenged with LPS or BA for 19 days showed significant increase in the immobility time, hyperalgesia and oxidative stress on the 19th day. Serum tumor necrosis factor-alpha (TNF-α) levels were also markedly increased with LPS or BA challenge. Concurrent treatment with olive extract resulted in a significant decrease in the immobility time as well as hyperalgesia. There was significant attenuation of oxidative stress as well as serum TNF-α levels. The results of the present study strongly indicate the role of oxidative stress and immunological activation in the pathophysiology of chronic fatigue syndrome and highlight the valuable role of olive extract in combating chronic fatigue syndrome.

Introduction

Chronic fatigue syndrome is characterized by debilitating fatigue, complicated by various physical and mental symptoms as a result of biochemical or immunological disturbances (Fukuda et al., 1994, Reeves et al., 2005). Due to its obscure and multifactorial etiology, it is difficult to diagnose and treat chronic fatigue syndrome. Major contributors in the development of chronic fatigue syndrome include physical stress, infection and imbalance in the antioxidant pool (Behan & Behan, 1988, Demitrack et al., 1991, Klimas & Koneru, 2007). In the light of ongoing research on chronic fatigue syndrome, it is speculated that a specific bacterial or viral infection and immune dysfunction act as potential stressors that result in the production of reactive oxygen species (ROS) such as superoxide ions, peroxides and nitric oxide (Gaab et al., 2005, Klimas & Koneru, 2007). Elevated level of prooxidants such as superoxide anion, nitric oxide and peroxynitrite results in the impairment of normal integrity and physiology of cellular function (Gaab et al., 2005, Pall & Satterlee, 2001). These intermediates mediate a large number of cytotoxic mechanisms such as lipid peroxidation, mitochondrial dysfunction and hence result in cellular injury and death (Yoshikawa et al., 1994).

Earlier clinical and experimental studies have highlighted the interaction of immunologic challenge and development of chronic fatigue syndrome (Chao et al., 1992). Immunogens such as lipopolysaccharide (LPS) endotoxin or Brucella abortus (BA) have been commonly implicated antigens in chronic fatigue syndrome (Gaab et al., 2005, Chao et al., 1992, Ottenweller et al., 1998). Antigens such as LPS or BA interact with the cellular system and stimulate the generation of reactive oxygen species such as superoxide anions, hydroxyl radicals and peroxynitrite formation as well as release of pro-inflammatory cytokines (Gaab et al., 2005, Sakaguchi & Furusawa, 2006, Sugino et al., 1987, Svetic et al., 1993). In order to attenuate the disabling mechanisms of chronic fatigue syndrome, nutritional supplements with potent antioxidant activity as well as dietary modification can be beneficial. Various in-vivo studies have been done where researchers have shown the beneficial effects of herbal products in animal models of chronic fatigue (Chen et al., 2008, Logan & Wong, 2001, Singal et al., 2005).

Prolivols, the natural byproduct of olive oil processing, are aqueous extracts of the olive fruit. Prolivols are rich in polyphenols as well as ‘hydroxytyrosol’, the main chemical constituent of prolivols (Schaffer et al., 2007, Visioli et al., 2000a). Numerous studies have been carried out on hydroxytyrosol, demonstrating their potential antioxidant properties (Goya et al., 2007, Maiuri et al., 2005, Rietjens et al., 2007, Visioli et al., 2000b). Our laboratory has earlier demonstrated the potential antioxidant properties of natural polyphenols such as curcumin and naringin in experimental model of chronic fatigue syndrome (Gupta et al., 2009, Vij et al., 2009).

In light of the above evidence, the present study was designed to evaluate the effect of prolivols, an olive fruit extract, in LPS- or BA-induced fatigue in a murine model of water-immersion stress.

Section snippets

Animals

Albino Laca mice (20–30 g) bred in the Central Animal House facility of Panjab University, Chandigarh, India, were used for the study. The animals had free access to standard rodent food pellets and water. They were acclimatized to the laboratory conditions one day before the experiment and daily at least for 1 h before the experiment. All the experiments were conducted between 09.00 and 17.00 h. The experimental protocols were approved by the Institutional Animal Ethics Committee and conducted

Effect of olive extract on LPS- or BA-induced fatigue on immobility time and stress-induced hyperalgesia

Fig. 1A and B shows the effect of LPS- or BA-induced fatigue on immobility time and stress-induced hyperalgesia, respectively. Challenge with LPS or BA significantly increased the mean immobility time as compared to vehicle group (P < 0.05). Chronic administration of olive extract (50–400 mg/kg) orally for 19 days produced a pronounced, significant (P < 0.05) and dose dependent decrease in immobility time in mice as compared to LPS or BA challenged group. Also, LPS or BA challenge significantly

Discussion

Various suggested hypotheses about the etiology and pathophysiology of chronic fatigue syndrome propose the involvement of specific bacterial or viral infection and the immune dysfunction associated with the infection (Behan & Behan, 1988, Demitrack et al., 1991, Klimas & Koneru, 2007). The criteria for defining and diagnosing chronic fatigue syndrome is very complex, and often based on the patient's symptoms, degree of fatigue and impairment (Reeves et al., 2005). Previous research has

References (38)

  • D. Buchwald et al.

    Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome

    J. Rheumatol.

    (1997)
  • R. Chen et al.

    Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41)

    Neurochem. Res.

    (2008)
  • M.A. Demitrack et al.

    Evidence for impaired activation of the hypothalamic–pituitary–adrenal axis in patients with chronic fatigue syndrome

    J. Clin. Endocrinol. Metab.

    (1991)
  • I.J. Elenkov et al.

    The sympathetic nerve—an integrative interface between two supersystems: the brain and the immune system

    Pharmacol. Rev.

    (2000)
  • L.F. Ferreira et al.

    Muscle-derived ROS and thiol regulation in muscle fatigue

    J. Appl. Physiol.

    (2008)
  • K. Fukuda et al.

    The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

    Ann. Intern. Med.

    (1994)
  • L. Goya et al.

    Effect of the olive oil phenol hydroxytyrosol on human hepatoma HepG2 cells. Protection against oxidative stress induced by tert-butylhydroperoxide

    Eur. J. Nutr.

    (2007)
  • N.G. Klimas et al.

    Chronic fatigue syndrome: inflammation, immune function and neuroendocrine interactions

    Curr. Rheumatol. Rep.

    (2007)
  • A.M. Lerner et al.

    IgM serum antibodies to Epstein–Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome

    In Vivo

    (2004)
  • Cited by (23)

    • Investigation of the effects of vanilloids in chronic fatigue syndrome

      2016, Brain Research Bulletin
      Citation Excerpt :

      MetHb causes reduction of GSH levels in normal cells which is found to be decreased in CFS patients (Manuel y Keenoy et al., 2000). Increased oxidative stress and decreased antioxidant defenses are related to the extent of symptomatology in CFS patients (Maes et al., 2011; Gupta et al., 2010; Kennedy et al., 2005). Maes et al. (2011) found that H2O2 and MDA levels in plasma were significantly higher in patients with CFS than in normal controls (Maes et al., 2011).

    • Inflammatory fatigue and sickness behaviour - Lessons for the diagnosis and management of chronic fatigue syndrome

      2012, Journal of Affective Disorders
      Citation Excerpt :

      These models have prompted the evaluation of immunological parameters such as cytokine production and leukocyte activation as possible biomarkers for the diagnosis of CFS (Aspler et al., 2008; Fletcher et al., 2009; Gow et al., 2009). As previously discussed, investigations targeting direct immune activation have produced mixed results (Raison et al., 2009), but indirect assays investigating products of oxidation (Fulle et al., 2000; Gupta et al., 2010; Jammes et al., 2009; Kennedy et al., 2005; Maes et al., 2011a; Manuel y Keenoy et al., 2001; Smirnova and Pall, 2003; Vecchiet et al., 2003) and anti-oxidant depletion (Maes et al., 2006a; Manuel y Keenoy et al., 2000; Miwa and Fujita, 2009) have produced more consistent indications of immune activation (summarised in Table 2). These results have been also interpreted as evidence that reactive oxygen and nitrogen species are key to the pathogenesis of CFS and are prime candidates for a clinically useful biomarker in CFS (Gharibzadeh and Hoseini, 2006; Logan and Wong, 2001; Maes and Twisk, 2010; Maes et al., 2011a).

    • Redox proteomics and drug development

      2011, Journal of Proteomics
      Citation Excerpt :

      Nonetheless, in humans OS is also involved in many diseases (Table 2). Examples include atherosclerosis/vascular aging [74], heart failure and myocardial infarction [75], nervous system diseases, such as Parkinson's and Alzheimer's disease (AD) [76], muscular dystrophy [77], fragile X syndrome [78] and chronic fatigue syndrome [79], but short-term OS may also be important in prevention of aging [80] through the induction of a process named mitochondrial hormesis (or mitohormesis) [81]. In parallel, as treatments for the diseases of youth and middle age have helped raise life expectancy significantly, OS has been growingly tied to aging through the gradual decline of cognitive capacity [82].

    • Chronic fatigue syndrome - A neuroimmunological model

      2011, Medical Hypotheses
      Citation Excerpt :

      Reactive oxygen species are produced during the inflammatory cascade, and have the capacity to interfere with neurological function by interfering with oxidative phosphorylation, an important factor considering the very high metabolic demands of brain tissue. Animal models of CFS have demonstrated a benefit from the use of antioxidants [58]. While the production of reactive oxygen species is not unique to CFS and may lack specificity, assays for their presence may prove useful as an adjunct to the clinical diagnostic criteria or in the ongoing assessment of CFS patients.

    View all citing articles on Scopus
    View full text